person

Eva V. B.

Country
Belgium
Department
Urology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 94 partner sites.

Specializations

Advanced Prostate Cancer

Focused on therapeutic strategies for prostate cancer at the most aggressive stages, emphasizing PSMA‑directed and hormone‑based interventions.

  • metastatic castration‑resistant prostate cancer
  • high‑risk recurrent prostate cancer
  • PSMA‑expressing prostate cancer
  • androgen deprivation therapy combined with novel agents

Emphasis on radiographic progression‑free survival and biomarker‑guided treatment selection.

Urothelial Carcinoma

Investigation of bladder and urothelial malignancies, including both immunotherapy‑naïve and experienced disease states.

  • urothelial carcinoma
  • muscle‑invasive bladder cancer
  • immune checkpoint inhibitor combinations
  • adjuvant immunotherapy

Targets disease‑free survival and optimal sequencing of systemic therapies.

Renal Cell Carcinoma

Clinical studies on both clear‑cell and non‑clear‑cell renal cell carcinoma, exploring targeted and immune‑based regimens.

  • clear cell renal cell carcinoma
  • non‑clear cell renal cell carcinoma
  • tivozanib plus nivolumab
  • PD‑L1 directed regimens

Endpoints include radiographic progression‑free survival and overall survival.

Metastatic Solid Tumors & Biomarker‑Driven Therapy

Broad exploration of advanced solid tumors across diverse histologies, guided by molecular alterations.

  • HER2‑positive solid tumors
  • KRAS/NRAS/BRAF wild‑type colorectal cancer
  • PTEN‑deficient prostate cancer
  • biomarker‑guided combination therapy

Aims to enhance response rates and durability of benefit across tumor types.

Cardiovascular & Metabolic Comorbidities in Oncology Patients

Evaluation of cardiovascular and metabolic conditions that intersect with cancer treatment pathways.

  • atherosclerotic cardiovascular disease
  • elevated lipoprotein(a)
  • chronic kidney disease
  • hypertension in cancer patients

Integrates cardioprotective strategies within oncologic protocols.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.